Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages.
|
J Invest Dermatol
|
2001
|
6.12
|
2
|
Sonic hedgehog signaling is essential for hair development.
|
Curr Biol
|
1998
|
5.58
|
3
|
Controls of hair follicle cycling.
|
Physiol Rev
|
2001
|
5.49
|
4
|
Noggin is a mesenchymally derived stimulator of hair-follicle induction.
|
Nat Cell Biol
|
1999
|
2.99
|
5
|
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress.
|
Physiol Rev
|
2000
|
2.98
|
6
|
Interleukin-15 protects from lethal apoptosis in vivo.
|
Nat Med
|
1997
|
2.22
|
7
|
Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling.
|
FASEB J
|
2000
|
2.09
|
8
|
Noggin is required for induction of the hair follicle growth phase in postnatal skin.
|
FASEB J
|
2001
|
1.95
|
9
|
Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth.
|
J Invest Dermatol
|
1993
|
1.88
|
10
|
Analysis of apoptosis during hair follicle regression (catagen)
|
Am J Pathol
|
1997
|
1.82
|
11
|
Graying: gerontobiology of the hair follicle pigmentary unit.
|
Exp Gerontol
|
2001
|
1.75
|
12
|
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15.
|
Blood
|
1999
|
1.71
|
13
|
What are melanocytes really doing all day long...?
|
Exp Dermatol
|
2009
|
1.65
|
14
|
Retracted
Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain.
|
FASEB J
|
1999
|
1.60
|
15
|
Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin.
|
J Lab Clin Med
|
1993
|
1.58
|
16
|
Melanocytes as "sensory" and regulatory cells in the epidermis.
|
J Theor Biol
|
1993
|
1.55
|
17
|
Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo.
|
FASEB J
|
2000
|
1.48
|
18
|
The human hair follicle immune system: cellular composition and immune privilege.
|
Br J Dermatol
|
2000
|
1.42
|
19
|
Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling.
|
J Invest Dermatol
|
1998
|
1.40
|
20
|
The 'melanocyte-keratin' mystery revisited: neither normal human epidermal nor hair follicle melanocytes express keratin 16 or keratin 6 in situ.
|
Br J Dermatol
|
2009
|
1.39
|
21
|
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?
|
Exp Dermatol
|
2008
|
1.39
|
22
|
The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis.
|
Dev Biol
|
1999
|
1.38
|
23
|
The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation.
|
Am J Pathol
|
1999
|
1.38
|
24
|
Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions.
|
Am J Pathol
|
1999
|
1.37
|
25
|
Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma.
|
Eur J Immunol
|
1998
|
1.37
|
26
|
Alkaline phosphatase activity and localization during the murine hair cycle.
|
Br J Dermatol
|
1994
|
1.34
|
27
|
Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans.
|
Exp Dermatol
|
1998
|
1.33
|
28
|
Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?
|
J Immunol
|
2000
|
1.29
|
29
|
Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis.
|
Anticancer Res
|
1999
|
1.29
|
30
|
Active hair growth (anagen) is associated with angiogenesis.
|
J Invest Dermatol
|
2000
|
1.29
|
31
|
Melanogenesis during the anagen-catagen-telogen transformation of the murine hair cycle.
|
J Invest Dermatol
|
1994
|
1.27
|
32
|
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling.
|
FASEB J
|
2000
|
1.26
|
33
|
Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair.
|
FASEB J
|
2009
|
1.25
|
34
|
Management of alopecia areata.
|
BMJ
|
2010
|
1.25
|
35
|
Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice.
|
J Invest Dermatol
|
1991
|
1.24
|
36
|
E- and P-cadherin expression during murine hair follicle morphogenesis and cycling.
|
Exp Dermatol
|
1999
|
1.22
|
37
|
Characterization of functional vanilloid receptors expressed by mast cells.
|
Blood
|
1998
|
1.21
|
38
|
Retracted
The IL-15R alpha chain signals through association with Syk in human B cells.
|
J Immunol
|
2001
|
1.20
|
39
|
Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin.
|
J Comp Neurol
|
1997
|
1.20
|
40
|
Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?".
|
Ann N Y Acad Sci
|
1999
|
1.18
|
41
|
Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle.
|
Br J Dermatol
|
1994
|
1.18
|
42
|
Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
|
Am J Pathol
|
1997
|
1.17
|
43
|
Indications for a 'brain-hair follicle axis (BHA)': inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P.
|
FASEB J
|
2001
|
1.17
|
44
|
What causes alopecia areata?
|
Exp Dermatol
|
2013
|
1.14
|
45
|
Towards defining the pathogenesis of the hairless phenotype.
|
J Invest Dermatol
|
1998
|
1.06
|
46
|
Proopiomelanocortin expression in the skin during induced hair growth in mice.
|
Experientia
|
1992
|
1.05
|
47
|
Distinct patterns of NCAM expression are associated with defined stages of murine hair follicle morphogenesis and regression.
|
J Histochem Cytochem
|
1998
|
1.05
|
48
|
On the potential role of proopiomelanocortin in skin physiology and pathology.
|
Mol Cell Endocrinol
|
1993
|
1.04
|
49
|
Evidence that the bulge region is a site of relative immune privilege in human hair follicles.
|
Br J Dermatol
|
2008
|
1.03
|
50
|
Keratin 17 gene expression during the murine hair cycle.
|
J Invest Dermatol
|
1997
|
1.03
|
51
|
Management of primary cicatricial alopecias: options for treatment.
|
Br J Dermatol
|
2008
|
1.03
|
52
|
Merkel cells in mouse skin: intermediate filament pattern, localization, and hair cycle-dependent density.
|
J Invest Dermatol
|
1996
|
1.02
|
53
|
Patterns of proliferation and apoptosis during murine hair follicle morphogenesis.
|
J Invest Dermatol
|
2001
|
1.02
|
54
|
Patterns of hairless (hr) gene expression in mouse hair follicle morphogenesis and cycling.
|
Am J Pathol
|
2000
|
1.00
|
55
|
Mutant laboratory mice with abnormalities in hair follicle morphogenesis, cycling, and/or structure: annotated tables.
|
Exp Dermatol
|
2001
|
1.00
|
56
|
Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin.
|
FASEB J
|
1998
|
0.99
|
57
|
How not to get scar(r)ed: pointers to the correct diagnosis in patients with suspected primary cicatricial alopecia.
|
Br J Dermatol
|
2009
|
0.99
|
58
|
Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles.
|
Br J Dermatol
|
2005
|
0.98
|
59
|
A role for p75 neurotrophin receptor in the control of apoptosis-driven hair follicle regression.
|
FASEB J
|
2000
|
0.98
|
60
|
Activated skin mast cells are involved in murine hair follicle regression (catagen).
|
Lab Invest
|
1997
|
0.98
|
61
|
High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo.
|
Br J Dermatol
|
2000
|
0.98
|
62
|
The bulge is the source of cellular renewal in the sebaceous gland of mouse skin.
|
Arch Dermatol Res
|
2000
|
0.98
|
63
|
Is our self based on reward? Self-relatedness recruits neural activity in the reward system.
|
Neuroimage
|
2007
|
0.97
|
64
|
Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7.
|
Br J Dermatol
|
2009
|
0.97
|
65
|
Hair-cycle-associated remodeling of the peptidergic innervation of murine skin, and hair growth modulation by neuropeptides.
|
J Invest Dermatol
|
2001
|
0.97
|
66
|
Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 act as "epitheliotrophins" in murine skin.
|
Lab Invest
|
1999
|
0.97
|
67
|
Molecular basis for the rhino Yurlovo (hr(rhY)) phenotype: severe skin abnormalities and female reproductive defects associated with an insertion in the hairless gene.
|
Exp Dermatol
|
1998
|
0.96
|
68
|
Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion.
|
J Histochem Cytochem
|
1998
|
0.96
|
69
|
Skin histoculture assay for studying the hair cycle.
|
In Vitro Cell Dev Biol
|
1993
|
0.95
|
70
|
Hair shaft elongation, follicle growth, and spontaneous regression in long-term, gelatin sponge-supported histoculture of human scalp skin.
|
Proc Natl Acad Sci U S A
|
1992
|
0.95
|
71
|
A new role for neurotrophin-3: involvement in the regulation of hair follicle regression (catagen).
|
Am J Pathol
|
1998
|
0.94
|
72
|
Glucocorticoid effect on hair growth initiation: a reconsideration.
|
Skin Pharmacol
|
1993
|
0.94
|
73
|
The nude mouse skin phenotype: the role of Foxn1 in hair follicle development and cycling.
|
Exp Mol Pathol
|
2001
|
0.94
|
74
|
What is the biological basis of pattern formation of skin lesions?
|
Exp Dermatol
|
2006
|
0.93
|
75
|
Do hair bulb melanocytes undergo apoptosis during hair follicle regression (catagen)?
|
J Invest Dermatol
|
1998
|
0.93
|
76
|
Hair cycle-dependent changes in adrenergic skin innervation, and hair growth modulation by adrenergic drugs.
|
J Invest Dermatol
|
1999
|
0.93
|
77
|
Are L-tyrosine and L-dopa hormone-like bioregulators?
|
J Theor Biol
|
1990
|
0.92
|
78
|
A role for p75 neurotrophin receptor in the control of hair follicle morphogenesis.
|
Dev Biol
|
1999
|
0.91
|
79
|
A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist.
|
J Invest Dermatol
|
2001
|
0.91
|
80
|
The fate of hair follicle melanocytes during the hair growth cycle.
|
J Investig Dermatol Symp Proc
|
1999
|
0.91
|
81
|
A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle--dependent changes in mast cell--nerve fiber contacts in murine skin.
|
Arch Dermatol Res
|
1997
|
0.90
|
82
|
Identification and characterization of two isozymic forms of arylamine N-acetyltransferase in Syrian hamster skin.
|
J Invest Dermatol
|
1993
|
0.90
|
83
|
Towards optimization of an organotypic assay system that imitates human hair follicle-like epithelial-mesenchymal interactions.
|
Br J Dermatol
|
2004
|
0.89
|
84
|
Mast cells as modulators of hair follicle cycling.
|
Exp Dermatol
|
1995
|
0.89
|
85
|
Murine skin as a target for melatonin bioregulation.
|
Exp Dermatol
|
1994
|
0.89
|
86
|
The 'follicular trochanter': an epithelial compartment of the human hair follicle bulge region in need of further characterization.
|
Br J Dermatol
|
2007
|
0.89
|
87
|
Differential regulation of human T lymphoblast functions by IL-2 and IL-15.
|
Cytokine
|
1997
|
0.89
|
88
|
Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs.
|
J Invest Dermatol
|
1998
|
0.89
|
89
|
Towards defining receptors for L-tyrosine and L-dopa.
|
Mol Cell Endocrinol
|
1994
|
0.88
|
90
|
Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone.
|
Ann N Y Acad Sci
|
1998
|
0.88
|
91
|
Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost.
|
Br J Dermatol
|
2010
|
0.88
|
92
|
Melanotropic activity of gamma MSH peptides in melanoma cells.
|
Life Sci
|
1992
|
0.87
|
93
|
Lichen planopilaris following hair transplantation and face-lift surgery.
|
Br J Dermatol
|
2012
|
0.87
|
94
|
Intact hair follicle innervation is not essential for anagen induction and development.
|
Arch Dermatol Res
|
1998
|
0.87
|
95
|
New roles for glial cell line-derived neurotrophic factor and neurturin: involvement in hair cycle control.
|
Am J Pathol
|
2000
|
0.87
|
96
|
Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ.
|
J Invest Dermatol
|
1996
|
0.87
|
97
|
Hair follicle apoptosis and Bcl-2.
|
J Investig Dermatol Symp Proc
|
1999
|
0.87
|
98
|
Epithelial growth by rat vibrissae follicles in vitro requires mesenchymal contact via native extracellular matrix.
|
J Invest Dermatol
|
1990
|
0.86
|
99
|
Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
|
Br J Dermatol
|
2012
|
0.86
|
100
|
Phenotypic indications that human sweat glands are a rich source of nestin-positive stem cell populations.
|
Br J Dermatol
|
2009
|
0.86
|
101
|
The proopiomelanocortin system in cutaneous neuroimmunomodulation. An introductory overview.
|
Ann N Y Acad Sci
|
1999
|
0.86
|
102
|
Hair cycle-dependent changes in the gene expression and protein content of transforming factor beta 1 and beta 3 in murine skin.
|
Arch Dermatol Res
|
1997
|
0.86
|
103
|
Hair cycle-dependent production of ACTH in mouse skin.
|
Biochim Biophys Acta
|
1998
|
0.85
|
104
|
Overexpression of Bcl-2 protects from ultraviolet B-induced apoptosis but promotes hair follicle regression and chemotherapy-induced alopecia.
|
Am J Pathol
|
2000
|
0.85
|
105
|
Characterization of stem cells in Dupuytren's disease.
|
Br J Surg
|
2011
|
0.85
|
106
|
The role of beliefs: lessons from a pilot study on illness perception, psychological distress and quality of life in patients with primary cicatricial alopecia.
|
Br J Dermatol
|
2014
|
0.84
|
107
|
Selective expression of calcium-binding proteins S100a8 and S100a9 at distinct sites of hair follicles.
|
J Invest Dermatol
|
2001
|
0.84
|
108
|
Hypothesis: possible role for the melatonin receptor in vitiligo: discussion paper.
|
J R Soc Med
|
1989
|
0.83
|
109
|
MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo.
|
J Invest Dermatol
|
1998
|
0.83
|
110
|
Neurotrophin-3 involvement in the regulation of hair follicle morphogenesis.
|
J Invest Dermatol
|
1998
|
0.83
|
111
|
Can some melanotropins modulate keratinocyte proliferation?
|
J Invest Dermatol
|
1991
|
0.82
|
112
|
Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates.
|
Br J Dermatol
|
2012
|
0.82
|
113
|
Developmentally regulated expression of alpha-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation.
|
Ann N Y Acad Sci
|
1999
|
0.82
|
114
|
Endocrine controls of primary adult human stem cell biology: thyroid hormones stimulate keratin 15 expression, apoptosis, and differentiation in human hair follicle epithelial stem cells in situ and in vitro.
|
Eur J Cell Biol
|
2010
|
0.82
|
115
|
Oral zinc sulphate causes murine hair hypopigmentation and is a potent inhibitor of eumelanogenesis in vivo.
|
Br J Dermatol
|
2006
|
0.82
|
116
|
IL-15-IgG2b fusion protein accelerates and enhances a Th2 but not a Th1 immune response in vivo, while IL-2-IgG2b fusion protein inhibits both.
|
Eur J Immunol
|
1998
|
0.82
|
117
|
A new method for double immunolabelling with primary antibodies from identical species.
|
J Immunol Methods
|
1996
|
0.82
|
118
|
Control of hair growth with parathyroid hormone (7-34).
|
J Invest Dermatol
|
1997
|
0.82
|
119
|
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCCD) affects keratin 1 and keratin 17 gene expression and differentially induces keratinization in hairless mouse skin.
|
J Invest Dermatol
|
1997
|
0.81
|
120
|
Expression of galectin-1 and -3 and of accessible binding sites during murine hair cycle.
|
Histol Histopathol
|
2000
|
0.81
|
121
|
The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ.
|
J Dermatol Sci
|
1997
|
0.81
|
122
|
BDNF overexpression induces differential increases among subsets of sympathetic innervation in murine back skin.
|
Eur J Neurosci
|
1998
|
0.81
|
123
|
What controls hair follicle cycling?
|
Exp Dermatol
|
1999
|
0.80
|
124
|
Differential distribution of haematopoietic and nonhaematopoietic progenitor cells in intralesional and extralesional keloid: do keloid scars provide a niche for nonhaematopoietic mesenchymal stem cells?
|
Br J Dermatol
|
2010
|
0.80
|
125
|
Overexpression of brain-derived neurotrophic factor increases Merkel cell number in murine skin.
|
J Invest Dermatol
|
1999
|
0.80
|
126
|
FGF5 and the murine hair cycle.
|
Arch Dermatol Res
|
1996
|
0.80
|
127
|
ACTH production in C57BL/6 mouse skin.
|
Ann N Y Acad Sci
|
1999
|
0.80
|
128
|
Retracted
An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppression.
|
Transplantation
|
2000
|
0.79
|
129
|
Biophysical monitoring of melanogenesis as a tool for pigment and hair research.
|
Arch Dermatol Res
|
1995
|
0.79
|
130
|
Distribution of constitutive nitric oxide synthase immunoreactivity and NADPH-diaphorase activity in murine telogen and anagen skin.
|
J Invest Dermatol
|
1994
|
0.79
|
131
|
Pterins in human hair follicle cells and in the synchronized murine hair cycle.
|
J Invest Dermatol
|
1998
|
0.79
|
132
|
Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro.
|
Br J Dermatol
|
2010
|
0.79
|
133
|
Increased airway responsiveness, allergy-type-I skin responses and systemic anaphylaxis in a humanized-severe combined immuno-deficiency mouse model.
|
Clin Exp Allergy
|
2004
|
0.79
|
134
|
Functional role of beta 1 integrin-mediated signalling in the human hair follicle.
|
Exp Cell Res
|
2007
|
0.79
|
135
|
A novel in-situ-zymography technique localizes gelatinolytic activity in human skin to mast cells.
|
Exp Dermatol
|
1998
|
0.78
|
136
|
Distinct roles for nerve growth factor and brain-derived neurotrophic factor in controlling the rate of hair follicle morphogenesis.
|
J Invest Dermatol
|
2000
|
0.78
|
137
|
Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejection.
|
Cancer Res
|
1998
|
0.77
|
138
|
Inhibition of melanogenesis for melanoma therapy?
|
J Invest Dermatol
|
1994
|
0.77
|
139
|
Gelatin sponge-supported histoculture of human nasal mucosa.
|
In Vitro Cell Dev Biol Anim
|
1995
|
0.77
|
140
|
The neuropeptide galanin is a novel inhibitor of human hair growth.
|
Br J Dermatol
|
2012
|
0.77
|
141
|
Spontaneous hair follicle cycling may influence the development of murine contact photosensitivity by modulating keratinocyte cytokine production.
|
Cell Immunol
|
1997
|
0.77
|
142
|
Identification and measurement of beta-endorphin levels in the skin during induced hair growth in mice.
|
Biochim Biophys Acta
|
1997
|
0.77
|
143
|
Inhibition of chemotherapy-induced keratinocyte apoptosis in vivo by an interleukin-15-IgG fusion protein.
|
J Invest Dermatol
|
1998
|
0.77
|
144
|
Hair growth-modulation by adrenergic drugs.
|
Exp Dermatol
|
1999
|
0.77
|
145
|
Hair cycle-dependent changes in skin immune functions: anagen-associated depression of sensitization for contact hypersensitivity in mice.
|
J Invest Dermatol
|
1996
|
0.77
|
146
|
Pro-opiomelanocortin expression and potential function of pro-opiomelanocortin products during induced hair growth in mice.
|
Ann N Y Acad Sci
|
1991
|
0.77
|
147
|
Intercellular adhesion molecule-1 and hair follicle regression.
|
J Histochem Cytochem
|
2000
|
0.77
|
148
|
α-Melanocyte-stimulating hormone: a protective peptide against chemotherapy-induced hair follicle damage?
|
Br J Dermatol
|
2014
|
0.77
|
149
|
Stress and the skin.
|
Exp Dermatol
|
2001
|
0.77
|
150
|
Sequential expression of glutathione-S-transferase isoenzymes during hair growth phases in mice and their relationship to caldesmon, phosphotyrosinase and VIP receptor protein.
|
Histol Histopathol
|
1995
|
0.76
|
151
|
Retracted
Enhanced inhibition of tumour growth and metastasis, and induction of antitumour immunity by IL-2-IgG2b fusion protein.
|
Scand J Immunol
|
2002
|
0.76
|
152
|
Hair cycle-dependent expression of heat shock proteins in hair follicle epithelium.
|
Int J Dermatol
|
1997
|
0.76
|
153
|
Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia?
|
Clin Exp Dermatol
|
2009
|
0.76
|
154
|
Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
|
Br J Dermatol
|
2006
|
0.76
|
155
|
Bomirski melanomas - a versatile and powerful model for pigment cell and melanoma research (review).
|
Int J Oncol
|
1993
|
0.76
|
156
|
The anagen hair cycle induces systemic immunosuppression of contact hypersensitivity in mice.
|
Cell Immunol
|
1998
|
0.76
|
157
|
Hair cycle-dependent changes in mast cell histochemistry in murine skin.
|
Arch Dermatol Res
|
1995
|
0.76
|
158
|
Is thyrotropin-releasing hormone a novel neuroendocrine modulator of keratin expression in human skin?
|
Br J Dermatol
|
2013
|
0.76
|
159
|
Expression of transforming growth factor beta isoforms and their receptors during hair growth phases in mice.
|
Histol Histopathol
|
1996
|
0.76
|
160
|
The "bulge-activation hypothesis" does not explain hair follicle cycling but may still be valid.
|
Am J Dermatopathol
|
1994
|
0.75
|
161
|
Female pattern hair loss: beyond an androgenic aetiology?
|
Br J Dermatol
|
2010
|
0.75
|
162
|
Elements of the interleukin-1 signaling system show hair cycle-dependent gene expression in murine skin.
|
Eur J Dermatol
|
1999
|
0.75
|
163
|
Dopamine is a novel, direct inducer of catagen in human scalp hair follicles in vitro.
|
Br J Dermatol
|
2012
|
0.75
|
164
|
Localization and abundance of fodrin during keratinocyte differentiation.
|
In Vitro Cell Dev Biol Anim
|
1994
|
0.75
|
165
|
Hair growth in vitro from histocultured skin.
|
In Vitro Cell Dev Biol
|
1992
|
0.75
|
166
|
[Vitamin D3 and its analogs as multifunctional steroid hormones. Molecular and clinical aspects from the dermatologic viewpoint].
|
Hautarzt
|
1994
|
0.75
|
167
|
The alpha-melanocyte stimulating hormone-related tripeptide K(D)PT stimulates human hair follicle pigmentation in situ under proinflammatory conditions.
|
Br J Dermatol
|
2008
|
0.75
|
168
|
Immunomodulatory effects of the alpha-melanocyte-stimulating hormone-related tripeptide K(D)PT on human scalp hair follicles under proinflammatory conditions.
|
Br J Dermatol
|
2009
|
0.75
|
169
|
Hair cycle-associated changes in splenocyte proliferation.
|
In Vivo
|
1997
|
0.75
|
170
|
[Sources of error in sonographic diagnosis of the rotator cuff].
|
Ultraschall Med
|
1991
|
0.75
|
171
|
Bulge-activation hypothesis (continued)
|
Am J Dermatopathol
|
1994
|
0.75
|
172
|
Primary cicatricial alopecias: a U.K. survey.
|
Br J Dermatol
|
2012
|
0.75
|
173
|
Retardation of hair follicle development by the deletion of TrkC, high-affinity neurotrophin-3 receptor.
|
J Invest Dermatol
|
1999
|
0.75
|
174
|
[Scar forming alopecia. Comments on classification, differential diagnosis and pathobiology].
|
Hautarzt
|
1998
|
0.75
|
175
|
Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth factor-β2/insulin-like growth factor-1-mediated regulation of the hair cycle in male and female human hair follicles in vitro.
|
Br J Dermatol
|
2014
|
0.75
|
176
|
Beta-adrenergic receptors in nasal tissue with reference to their role in asthma and atopy.
|
Allergol Immunopathol (Madr)
|
1989
|
0.75
|